ANTALYA
 
 

A. Conference Program and Content

Abstracts submitted for the congress should be prepared in English. Oral presentations can be made either in English or Turkish as simultaneous interpretation (Turkish-English-Turkish) will be held. Language preference belongs to the speaker. Visual elements should be prepared in PowerPoint both in Turkish and English and should be given to the audiovisual technician at least 3 hours prior to the programmed talk.

Abstracts of research studies and case presentations, written in English, peer reviewed, and accepted as oral or poster presentation during the congress will be published in the Supplement Issue of TAP's official journal, Psychiatry & Clinical Psychopharmacology which is indexed by Science Citation Index Expanded (SCI-E). The abstracts of research studies should be consisted of four parts; objective, methods, results and conclusions, 450‒500 words and 5‒6 keywords.
For detailed information please visit: http://tandfonline.com

B. Session Types in the Program

1. Plenary/Keynote Lectures
The speakers for these sessions are selected by the chairpersons and invited by the Organizing Committee. Further submissions for Plenary/Keynote Lectures are not usually accepted, but if you have an exceptional proposal (as well as prior permission from the proposed speaker where applicable) please contact the congress Secretariat at icp2018@valor.com.tr

The abstract should be written in English, include 450‒500 words and according to Psychiatry and Clinical Psychopharmacology rules 5‒6 keywords should be added. If necessary 3 references can be added.

2. Oral Symposia
Oral symposia are submitted to the Program Committee by small groups of individuals who put together a 90-minute symposium with at least 4 speakers and two discussant moderators. The submitting speaker/session organizer must have prior permission from all the proposed speakers and will be the main point of contact responsible for all communications.

The abstract should be written in English, include 450‒500 words and according to Psychiatry and Clinical Psychopharmacology rules 5‒6 keywords should be added. If necessary 3 references can be added.
It should be an accurate reflection of the content of the presentation.
These will be three parallel sessions and simultaneous interpretation will be provided.

3. Oral Sessions/ Interactive
These are individual oral presentations of 60 minutes in total. The speakers are requested to limit their talk to 20‒25 minutes to allow some time for discussion at the end of the session.

The abstract should be written in English, include 450‒500 words and according to Psychiatry and Clinical Psychopharmacology rules 5‒6 keywords should be added. If necessary 3 references can be added.

4. Oral Presentations
These are 10-minute rapid communications, which will be grouped of 8 presentations at a time, making a ninety minute session. The speakers are required to deliver 8 minutes speech with 8 slides and 2 minutes for discussion at the end of each talk.

5. Poster Presentations
• Posters should be written in English.
• References (maximum 5) should be written on the poster in smaller font size, maximum 12.
• Other parts of the poster should be prepared as readable from a distance of minimum 1.5 meters.
• Poster size should be 90 cm in height and 70 cm in width.
• Research posters should be composed of four parts; objective, methods, results, and conclusions.
• Case posters should be composed of four parts; introduction, case presentation, discussion and conclusion.
• Award nominee research study posters will be displayed in related areas during the whole congress. Other posters will be split into 3 groups and poster presenters will put up their poster at 08:30 on the presentation day and remove them at 21:00 on the same day.

Important Note About Assistant Scholarship: Abstract presenters are required to register for the congress. The presenter’s registration will be confirmed as complimentary on the condition that the presenter is a psychiatry resident or post graduate student for whom provides the related official documentation. As this complimentary registration is made only for abstract presenter, it does not include co-authors.

C. Abstracts Applying for Research Awards

Main Topic
The abstract which gives a summary of the related research should be submitted. Names, academic titles, institutions, and addresses of authors should be written together with the e-mail address and cell phone number of the corresponding author.

Content
In addition to an abstract with 450‒500 words at the beginning, research award nominees should also provide a text in Brief Report format with maximum 1,500 words excluding the title, author names, institutions, and addresses. The abstract should be structured in four parts (Objective, Methods, Results, and Conclusions). 5-6 keywords must be added.

– Objective: Tested hypothesis or analyzed/searched target of the research should be explained.
– Methods: The study participants, location, setting, instruments used, data collection, and statistical analysis should be explained.
– Results: All results and findings of the research should be explained clearly.
– Conclusions: All the conclusions, their importance and possible implications should be explained clearly.

• Abstracts should require novel primary data research in research field of psychopharmacology, neuroscience, adult psychiatry and child and adolescent psychiatry and should not be published previously.
• Abbreviations and market names for special medications cannot be used.
• While common abbreviations can directly be used, for rare abbreviations, its expansion must be written in first sentence with the abbreviation in parenthesis.
All psychiatric medications should be identified clearly.
• The research field of the presentation should be mentioned by submitting the abstract under related category.

Layout
• The abstracts must be submitted in English.
• The abstract text should be checked by the corresponding author to eliminate typos and spelling mistakes.

Authors
• The institutions of the authors must be correctly sko
tated during the submission.
• The presenter name should be underlined.

Keywords
• 5-6 keywords from Medical Subject Heading (MeSH) that are controlled by National Library of Medicine (NLM) and used for article indexing of PubMed should be added.

References
• Maximum 3 references can be added. Within the text consecutive numbers can be referred between brackets; [1], [2] ve [3].

References can be stated as in the example below:

Kose S, Celikel FC, Akin E, Kaya C, Cumurcu B, Etikan I, Cloninger CR. Normative Data and Factorial Structure of the Turkish Version of the Junior Temperament and Character Inventory-Revised (J TCI-R). Psychiatry and Clinical Psychopharmacology 2017;27(1): 6-13.

Abstract Review Process Evaluation Criteria
1. Is there a clear background and justified objective?
2. Is the methodology/study design appropriate for the objectives?
3. Are the results important and clearly presented?
4. Are the conclusions supported by the results?
5. Is the study original, does it contribute to the field?
6. Clinical applicability of topic?
7. Quality of content and delivery?
8. Quality of language and formatting?
9. Meeting 1,500 word, 5-6 references rule, references per NLM format?

Publication
The oral and poster abstracts, case reports accepted by the scientific committee and presented in the congress will be included in the Congress USB and the USB will be given to all registered participants. Also its content will be published in the Congress Supplementary Issue of Psychiatry and Clinical Psychopharmacology.

Research abstracts properly written in Brief Report format and followed the steps as mentioned in Article C will be published in the Congress Supplementary Issue of Psychiatry and Clinical Psychopharmacology. The publisher of Psychiatry and Clinical Psychopharmacology holds the copyrights of the published texts. The authors accept the responsibility of the issues about violating the copyright and conflict of interests while submitting their abstracts.